NORDIC Regimen
The NORDIC regimen is a long-standing intensive induction protocol designed for young, fit patients with advanced-stage MCL.
- Protocol Structure: It utilizes R-maxi-CHOP alternating with rituximab plus high-dose cytarabine (Ara-C).
- Clinical Goal: This regimen aims for maximal disease control prior to consolidation with ASCT.